New program to educate pharmacists on pharmacogenomics. The efforts are going forward to help the pharmacists also explain to the patients how it works and what the information has to offer. The new group of graduates will be the first group of pharmacists to be information equipped. ...
Posted to
The Medical Quack .... by Barbara Duck
on 10-24-2008
Filed under: Medically Related, Technology, Other Items of Interest, Genomics, drugs, Pharmacy, DNA Testing, Phamaceuticals, Pharmacogonomics, healthare
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
Posted to
The Medical Quack .... by Barbara Duck
on 10-06-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Education, FDA, Pharmaceuticals, Pharmacogenomics, DNA Testing
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
on 09-19-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
It seems not a week goes by without a warning being issued from the FDA, so this looks to be a sign of the times, not to put anyone out of business, but to create an awareness. This is transparency folks and the warnings will keep on coming, so get used to it. Who knows, perhaps the competition...
I don't think anyone can debate the fact that medicine is getting tougher from every angle. New business models along with the daily research and genome updates have a tendency to make things a little shaky and unpredictable. The fact that he is from Pfizer, doesn't make much difference...
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
Posted to
The Medical Quack .... by Barbara Duck
on 09-05-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Biotech, Cancer, FDA, Budgets, R and D, Alzheimers, Outsourcing
Intellectual Property on the auction block, patents with FDA approval. This is the first time I have noticed technology with health care just up on the open auction block, especially as it relates to cancer research. With the acquisition, it must not fit into the same business model...